Roivant Sciences Ltd. (ROIV) Earnings
|
Expand Research on ROIV
| Next EPS Date | 11/16/26 | EPS Growth Rate | -111.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +58.5% | Revenue Growth Rate | +117.2% |
| Average % Move 1-Wk after EPS | +8.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/16/26 |
Q227 | N/A | -$0.36 | N/A | N/A | $3.41M | N/A | N/A | N/A | ||
| 8/6/26 |
Q127 | -$0.26 | -$0.30 | +$0.04 | $1.44M | $2.32M | N/A | ![]() | ![]() | Details | |
| 5/20/26 | Q426 | $0.28 | -$0.29 | +$0.57 | $2.52M | $3.76M | N/A | ![]() | ![]() | Details | |
| 2/6/26 | Q326 | -$0.38 | -$0.31 | -$0.07 | $1.99M | $5.13M | N/A | ![]() | ![]() | Details | |
| 11/10/25 | Q226 | -$0.17 | -$0.32 | +$0.15 | $1.57M | $5.6M | N/A | ![]() | ![]() | Details | |
| 8/11/25 | Q126 | -$0.33 | -$0.25 | -$0.08 | $2.17M | $7.69M | N/A | ![]() | ![]() | Details | |
| 5/29/25 |
Q425 | N/A | -$0.26 | N/A | N/A | $54.07M | N/A | N/A | N/A | ||
| 2/10/25 | Q325 | $0.23 | -$0.25 | +$0.48 | $9.02M | $8.14M | N/A | ![]() | ![]() | Details |


